Alere Inc (ALR) Poised for Margin Expansion

October 30, 2015

alere-logo  alere i

Analyst Dane Leone of BTIG, LLC says one of the stocks that he likes on the midcap side is Alere Inc (ALR).

“Over the past 12 months they’ve had several success with new products, and one of those being Alere i platform, which is the first molecular platform for the near-patient setting or CLIA waiver setting in the U.S. It has done very well with potentially over 2,000 placements currently within the first nine months of launch with a significant opportunity ahead globally in best-in-class technology,” Leone says.

The new product cycle coupled with the new management creates a significant opportunity for Alere to expand the margins, Leone says.

“We think that makes Alere the most interesting re-emerging growth company in this space,” he says.